Search - tctmd.com

Displaying 321 - 332 of 332

Sort: Relevancy | Date

News Industry News

Medtronic Resolute® Drug-Eluting Stent Exhibits Strong Safety Profile in Broad Spectrum of Patients

May 20, 2011

News Industry News

Axxess™ Self-Expanding Bifurcation Drug-Eluting Stent Shown To Be Safe And Effective Up To Three Years

May 19, 2011

News Industry News

Plans For Largest Ever Drug-Eluting Stent Randomized Clinical Trial Announced at EuroPCR

May 18, 2011

News Daily News

Two-Year Data Published from SPIRIT IV, COMPARE: Xience Still Favored Over Taxus

April 20, 2011

News Conference News

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

Caitlin E. Cox

April 04, 2011

News Industry News

Medtronic Resolute® Drug-Eluting Stent Delivers Compelling Clinical Outcomes in Major Studies

April 04, 2011

News Industry News

Medtronic to Unveil Pivotal U.S. Data on Resolute® Drug-Eluting Stent at ACC.11

March 28, 2011

News Daily News

SYNTAX Analysis: PCI, CABG Offer Substantial Symptom Relief But Timing Differs

Caitlin E. Cox

March 16, 2011

News Conference News

SYNTAX Left Main: PCI Provides Similar Angina Relief to CABG at Lower Cost

Caitlin E. Cox

February 15, 2011

News Daily News

DES Linked with More Stent Thrombosis Than BMS 1 Year After Primary PCI

January 18, 2011

News

SYNTAX Published: CABG Remains Standard for Severe CAD

Caitlin E. Cox

February 18, 2009

Video

BIODEGRADE: A Large-Scale Randomized Trial of a Thin-Strut Bioabsorbable Polymer-Based DES vs. a Thick-Strut Bioabsorbable Polymer-Based DES in an All-Comers Population With Coronary Artery Disease

September 29, 2019

Advertisement

Medtronic Resolute® Drug-Eluting Stent Exhibits Strong Safety Profile in Broad Spectrum of Patients

Axxess™ Self-Expanding Bifurcation Drug-Eluting Stent Shown To Be Safe And Effective Up To Three Years

Plans For Largest Ever Drug-Eluting Stent Randomized Clinical Trial Announced at EuroPCR

Two-Year Data Published from SPIRIT IV, COMPARE: Xience Still Favored Over Taxus

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

Medtronic Resolute® Drug-Eluting Stent Delivers Compelling Clinical Outcomes in Major Studies

Medtronic to Unveil Pivotal U.S. Data on Resolute® Drug-Eluting Stent at ACC.11

SYNTAX Analysis: PCI, CABG Offer Substantial Symptom Relief But Timing Differs

SYNTAX Left Main: PCI Provides Similar Angina Relief to CABG at Lower Cost

DES Linked with More Stent Thrombosis Than BMS 1 Year After Primary PCI

SYNTAX Published: CABG Remains Standard for Severe CAD

BIODEGRADE: A Large-Scale Randomized Trial of a Thin-Strut Bioabsorbable Polymer-Based DES vs. a Thick-Strut Bioabsorbable Polymer-Based DES in an All-Comers Population With Coronary Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content